Related Experiment Video
Updated: Aug 15, 2026

Investigation of Genetic Dependencies Using CRISPR-Cas9-based Competition Assays
Published on: January 7, 2019
The suppression of SH3BGRL is important for v-Rel-mediated transformation
1Section of Molecular Genetics and Microbiology, Institute of Cellular and Molecular Biology, University of Texas at Austin, Austin, TX 78712-1095, USA.
Abstract:
The v-rel oncogene is the most efficient transforming member of the Rel/NF-kappaB family of transcription factors. v-Rel induces avian and mammalian lymphoid cell tumors and transforms chicken embryo fibroblasts in culture by the aberrant regulation of genes under the control of Rel/NF-kappaB proteins. Here we report that the expression of SH3BGRL, a member of the SH3BGR (SH3 domain-binding glutamic acid-rich) family of proteins, is downregulated in v-Rel-expressing fibroblasts, lymphoid cells, and splenic tumor cells. Chromatin immunoprecipitation experiments demonstrated that v-Rel binds to the sh3bgrl promoter in transformed cells. Coexpression of SH3BGRL with v-Rel in primary splenic lymphocytes reduced the number of colonies formed by 76%. Mutations in the predicted SH3-binding domain of SH3BGRL abolished the suppressive effect on v-Rel transformation and resulted in colony numbers comparable to those formed by v-Rel alone. However, mutations in the predicted EVH1-binding domain of SH3BGRL only had a modest effect on suppression of v-Rel transformation. This study provides the first example of a gene that is downregulated in v-Rel-expressing cells that also plays a role in v-Rel transformation.
Insights
The v-Rel oncogene downregulates SH3BGRL, a protein involved in cell transformation. Suppressing v-Rel
Area of Science:
- Oncology
- Molecular Biology
- Gene Regulation
Background:
- The v-Rel oncogene, a potent member of the Rel/NF-kappaB transcription factor family, drives lymphoid cell tumors and transforms fibroblasts.
- Aberrant gene regulation by Rel/NF-kappaB proteins underlies v-Rel's oncogenic activity.
Purpose of the Study:
- To investigate the role of SH3BGRL (SH3 domain-binding glutamic acid-rich) in v-Rel-mediated cell transformation.
- To identify genes downregulated by v-Rel that are functionally involved in its oncogenic effects.
Main Methods:
- Quantitative analysis of SH3BGRL expression in v-Rel-expressing cells (fibroblasts, lymphoid cells, splenic tumors).
- Chromatin immunoprecipitation (ChIP) to assess v-Rel binding to the sh3bgrl promoter.
- Coexpression studies of SH3BGRL and v-Rel in primary splenic lymphocytes, including mutational analysis of SH3BGRL domains.
Main Results:
- SH3BGRL expression is significantly downregulated in v-Rel-transformed cells.
- v-Rel directly binds to the sh3bgrl promoter in transformed cells.
- Overexpression of SH3BGRL suppresses v-Rel-induced transformation by 76%; mutations in the SH3-binding domain abolish this suppression, while EVH1-binding domain mutations have a minor effect.
Conclusions:
- SH3BGRL is a novel tumor suppressor downregulated by v-Rel.
- The SH3-binding domain of SH3BGRL is critical for its suppressive role in v-Rel transformation.
- This study identifies a new mechanism of oncogenesis involving v-Rel-mediated downregulation of a tumor suppressor gene.
Related Concept Videos
Abnormal Proliferation
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
TGF - β Signaling Pathway
In-vitro Mutagenesis
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

